172 related articles for article (PubMed ID: 28324052)
1. Skeletal Complications and Mortality in Thyroid Cancer: A Population-Based Study.
Choksi P; Papaleontiou M; Guo C; Worden F; Banerjee M; Haymart M
J Clin Endocrinol Metab; 2017 Apr; 102(4):1254-1260. PubMed ID: 28324052
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of bone metastases resulting from thyroid cancer: a review of 28 patients over a 20-year period.
Do MY; Rhee Y; Kim DJ; Kim CS; Nam KH; Ahn CW; Cha BS; Kim KR; Lee HC; Park CS; Lim SK
Endocr J; 2005 Dec; 52(6):701-7. PubMed ID: 16410661
[TBL] [Abstract][Full Text] [Related]
3. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
[TBL] [Abstract][Full Text] [Related]
4. Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic Morphology.
Vogel T; Wendler J; Frank-Raue K; Kreissl MC; Spitzweg C; Fassnacht M; Raue F; Kroiss M
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32072159
[TBL] [Abstract][Full Text] [Related]
5. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
6. Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma.
Xu JY; Murphy WA; Milton DR; Jimenez C; Rao SN; Habra MA; Waguespack SG; Dadu R; Gagel RF; Ying AK; Cabanillas ME; Weitzman SP; Busaidy NL; Sellin RV; Grubbs E; Sherman SI; Hu MI
J Clin Endocrinol Metab; 2016 Dec; 101(12):4871-4877. PubMed ID: 27662441
[TBL] [Abstract][Full Text] [Related]
7. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.
Zaydfudim V; Feurer ID; Griffin MR; Phay JE
Surgery; 2008 Dec; 144(6):1070-7; discussion 1077-8. PubMed ID: 19041020
[TBL] [Abstract][Full Text] [Related]
8. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
9. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
Bhattacharyya N
Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
[TBL] [Abstract][Full Text] [Related]
10. Early prognostic factors at the time of diagnosis of bone metastasis in patients with bone metastases of differentiated thyroid carcinoma.
Choi YM; Kim WG; Kwon H; Jeon MJ; Lee JJ; Ryu JS; Hong EG; Kim TY; Shong YK; Kim WB
Eur J Endocrinol; 2016 Sep; 175(3):165-72. PubMed ID: 27272238
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and prognostic factors in thyroid cancer patients with cranial metastases: A retrospective cohort study of 4,683 patients.
Hong YW; Lin JD; Yu MC; Hsu CC; Lin YS
Int J Surg; 2018 Jul; 55():182-187. PubMed ID: 29883619
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis.
Pellegriti G; Giuffrida D; Scollo C; Vigneri R; Regalbuto C; Squatrito S; Belfiore A
Cancer; 2002 Nov; 95(10):2076-85. PubMed ID: 12412160
[TBL] [Abstract][Full Text] [Related]
13. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer.
Yang L; Shen W; Sakamoto N
J Clin Oncol; 2013 Feb; 31(4):468-74. PubMed ID: 23270002
[TBL] [Abstract][Full Text] [Related]
14. Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer.
Kim SJ; Myong JP; Suh H; Lee KE; Youn YK
PLoS One; 2015; 10(6):e0130848. PubMed ID: 26102084
[TBL] [Abstract][Full Text] [Related]
15. Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999-2006.
Sathiakumar N; Delzell E; Morrisey MA; Falkson C; Yong M; Chia V; Blackburn J; Arora T; Brill I; Kilgore ML
Breast Cancer Res Treat; 2012 Jan; 131(1):231-8. PubMed ID: 21842243
[TBL] [Abstract][Full Text] [Related]
16. The Clinical and Economic Impacts of Skeletal-Related Events Among Medicare Enrollees With Prostate Cancer Metastatic to Bone.
McDougall JA; Bansal A; Goulart BH; McCune JS; Karnopp A; Fedorenko C; Greenlee S; Valderrama A; Sullivan SD; Ramsey SD
Oncologist; 2016 Mar; 21(3):320-6. PubMed ID: 26865591
[TBL] [Abstract][Full Text] [Related]
17. Papillary and follicular thyroid carcinomas with bone metastases: a series of 39 cases during a period of 18 years.
Fanchiang JK; Lin JD; Huang MJ; Shih HN
Changgeng Yi Xue Za Zhi; 1998 Dec; 21(4):377-82. PubMed ID: 10074721
[TBL] [Abstract][Full Text] [Related]
18. Skeletal-related events due to bone metastases from differentiated thyroid cancer.
Farooki A; Leung V; Tala H; Tuttle RM
J Clin Endocrinol Metab; 2012 Jul; 97(7):2433-9. PubMed ID: 22564664
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
Xu B; Ibrahimpasic T; Wang L; Sabra MM; Migliacci JC; Tuttle RM; Ganly I; Ghossein R
Thyroid; 2016 Nov; 26(11):1588-1597. PubMed ID: 27480016
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
